Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Discure Technologies appoints Dr. Ray Baker to its Board of Directors, and fractional Chief Medical Officer, supporting the company onto its next stage.
-
ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in...
-
CARMEL, Ind., April 22, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
-
Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, today announced U.S. Food...
-
“We are pleased to welcome Don Payerle to our Board of Managers,” said Aure Bruneau, Chief Executive Officer of Curonix.
-
Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, today announced the closing...
-
SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s pivotal...
-
AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth...
-
Restore Brain executive John Cavanagh shared neuroscience-based insights on TMS during a recent behavioral health summit held in Dallas.
-
PathMaker Neurosystems Board Director, John Donoghue, Ph.D., Awarded 2026 Queen Elizabeth Prize for Engineering